高甘油三酯血症及其心血管风险管理专家共识

2017-02-20 中国胆固醇教育计划委员会 中华心血管杂志.2017,45(2):108-115.

近年来,随着新的临床研究结果及指南的发布,临床医生对血脂异常的管理理念也在不断更新。在积极降低LDL-C水平防治ASCVD基础上,为进一步完善和优化我国HTG及其相关心血管剩留风险的临床管理与实践,中国胆固醇教育计划委员会组织专家共同商讨,根据中国患者血脂异常特点,参考国内外临床研究证据和相应共识指南,制定本共识,旨在为临床医生提供更为科学合理的诊疗建议。

中文标题:

高甘油三酯血症及其心血管风险管理专家共识

发布日期:

2017-02-20

简要介绍:

近年来,随着新的临床研究结果及指南的发布,临床医生对血脂异常的管理理念也在不断更新。在积极降低LDL-C水平防治ASCVD基础上,为进一步完善和优化我国HTG及其相关心血管剩留风险的临床管理与实践,中国胆固醇教育计划委员会组织专家共同商讨,根据中国患者血脂异常特点,参考国内外临床研究证据和相应共识指南,制定本共识,旨在为临床医生提供更为科学合理的诊疗建议。

 

拓展指南:心血管相关指南:

相关资料下载:
[AttachmentFileName(sort=100, fileName=高甘油三酯血症及其心血管风险管理专家共识)] GetToolGuiderByIdResponse(projectId=1, id=4ab7b1c001a82218, title=高甘油三酯血症及其心血管风险管理专家共识, enTitle=, guiderFrom=中华心血管杂志.2017,45(2):108-115., authorId=null, author=, summary=近年来,随着新的临床研究结果及指南的发布,临床医生对血脂异常的管理理念也在不断更新。在积极降低LDL-C水平防治ASCVD基础上,为进一步完善和优化我国HTG及其相关心血管剩留风险的临床管理与实践,中国胆固醇教育计划委员会组织专家共同商讨,根据中国患者血脂异常特点,参考国内外临床研究证据和相应共识指南,制定本共识,旨在为临床医生提供更为科学合理的诊疗建议。 , cover=, journalId=null, articlesId=null, associationId=1501, associationName=中国胆固醇教育计划委员会, associationIntro=, copyright=0, guiderPublishedTime=Mon Feb 20 00:00:00 CST 2017, originalUrl=, linkOutUrl=, content=<P>近年来,随着新的临床研究结果及指南的发布,临床医生对血脂异常的管理理念也在不断更新。在积极降低LDL-C水平防治ASCVD基础上,为进一步完善和优化我国HTG及其相关心血管剩留风险的临床管理与实践,中国胆固醇教育计划委员会组织专家共同商讨,根据中国患者血脂异常特点,参考国内外临床研究证据和相应共识指南,制定本共识,旨在为临床医生提供更为科学合理的诊疗建议。 </P> <P> </P>拓展指南:<STRONG>与<FONT color=red>心血管</FONT>相关指南:</STRONG><BR> <UL> <LI><A title=阿司匹林在动脉粥样硬化性心血管疾病中的临床应用:中国专家共识(2016) target=_blank href="http://www.medsci.cn/guideline/show_article.do?id=8792e1c001ae80b5">阿司匹林在动脉粥样硬化性心血管疾病中的临床应用:中国专家共识(2016)</A> <LI><A title=中国女性心血管疾病预防专家共识 target=_blank href="http://www.medsci.cn/guideline/show_article.do?id=c479e1c001ae008d">中国女性心血管疾病预防专家共识</A> <LI><A title=《心血管疾病合并失眠诊疗中国专家共识》(2017)简读 target=_blank href="http://www.medsci.cn/guideline/show_article.do?id=d34af1c001a69460">《心血管疾病合并失眠诊疗中国专家共识》(2017)简读</A> <LI><A title=心血管疾病合并失眠诊疗中国专家共识 target=_blank href="http://www.medsci.cn/guideline/show_article.do?id=5005e1c001a693c3">心血管疾病合并失眠诊疗中国专家共识</A> <LI><A title=2型糖尿病合并动脉粥样硬化性心血管疾病患者降糖药物应用专家共识 target=_blank href="http://www.medsci.cn/guideline/show_article.do?id=07fcf1c001a668d7">2型糖尿病合并动脉粥样硬化性心血管疾病患者降糖药物应用专家共识</A> 更多信息请点击:<A target=_blank href="http://www.medsci.cn/guideline/list.do?q=%E5%BF%83%E8%A1%80%E7%AE%A1">有关心血管更多指南</A></LI></UL>, tagList=[TagDto(tagId=5537, tagName=高甘油三酯血症), TagDto(tagId=1567, tagName=心血管风险)], categoryList=[CategoryDto(categoryId=2, categoryName=心血管, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=1, guiderRegion=3, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=6864, appHits=463, showAppHits=1, pcHits=4875, showPcHits=2440, likes=172, shares=23, comments=3, approvalStatus=1, publishedTime=Fri Aug 11 21:30:34 CST 2017, publishedTimeString=2017-02-20, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Fri Aug 11 21:30:34 CST 2017, updatedBy=null, updatedName=null, updatedTime=Sat Jan 06 11:55:39 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=高甘油三酯血症及其心血管风险管理专家共识)])
高甘油三酯血症及其心血管风险管理专家共识
下载请点击:
评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=236475, encodeId=e82d2364e5f8, content=谢谢了.学习学习!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/03/19/68358be9323aa8e32edd53bfd17742f1.jpg, createdBy=5a191960665, createdName=1e135751m36(暂无匿称), createdTime=Wed Aug 23 23:19:00 CST 2017, time=2017-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=233137, encodeId=485423313e4f, content=谢谢,学习一下知识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160718/IMG578C993D395567540.jpg, createdBy=59b81918946, createdName=flysky120, createdTime=Sun Aug 13 09:48:48 CST 2017, time=2017-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=233072, encodeId=19a22330e2b0, content=学习了新知识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Sun Aug 13 07:35:52 CST 2017, time=2017-08-13, status=1, ipAttribution=)]
    2017-08-23 1e135751m36(暂无匿称)

    谢谢了.学习学习!

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=236475, encodeId=e82d2364e5f8, content=谢谢了.学习学习!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/03/19/68358be9323aa8e32edd53bfd17742f1.jpg, createdBy=5a191960665, createdName=1e135751m36(暂无匿称), createdTime=Wed Aug 23 23:19:00 CST 2017, time=2017-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=233137, encodeId=485423313e4f, content=谢谢,学习一下知识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160718/IMG578C993D395567540.jpg, createdBy=59b81918946, createdName=flysky120, createdTime=Sun Aug 13 09:48:48 CST 2017, time=2017-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=233072, encodeId=19a22330e2b0, content=学习了新知识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Sun Aug 13 07:35:52 CST 2017, time=2017-08-13, status=1, ipAttribution=)]
    2017-08-13 flysky120

    谢谢,学习一下知识

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=236475, encodeId=e82d2364e5f8, content=谢谢了.学习学习!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/03/19/68358be9323aa8e32edd53bfd17742f1.jpg, createdBy=5a191960665, createdName=1e135751m36(暂无匿称), createdTime=Wed Aug 23 23:19:00 CST 2017, time=2017-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=233137, encodeId=485423313e4f, content=谢谢,学习一下知识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160718/IMG578C993D395567540.jpg, createdBy=59b81918946, createdName=flysky120, createdTime=Sun Aug 13 09:48:48 CST 2017, time=2017-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=233072, encodeId=19a22330e2b0, content=学习了新知识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Sun Aug 13 07:35:52 CST 2017, time=2017-08-13, status=1, ipAttribution=)]
    2017-08-13 Y—xianghai

    学习了新知识

    0